Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is.

Du, Lixin; Zhang, Yu; Wang, Pan; Li, Zhigang; Zhao, Yunhui

Du, Lixin; Zhang, Yu; Wang, Pan; Li, Zhigang; Zhao, Yunhui.

Afiliación

Du L; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Zhang Y; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Wang P; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Li Z; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Zhao Y; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, China.

Front Cardiovasc Med ; 9: 1034095, 2022.

Article en En | MEDLINE | ID: mdl-36330012

Palabras clave

cardiovascular; death; glucagon-like peptide 1 receptor agonists; heart failure; sodium-glucose cotransporter 2 inhibitors; stroke

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google